Laboratory critical values: Automated notification supports effective clinical decision making

被引:52
作者
Piva, Elisa [1 ]
Pelloso, Michela [1 ]
Penello, Laura [1 ]
Plebani, Mario [1 ]
机构
[1] Univ Padua, Sch Med, Dept Lab Med, Padua, Italy
关键词
Critical value reporting; Patient safety; Effectiveness of critical value notification; Clinical outcomes; Clinical decision-making; ERRORS; SERUM;
D O I
10.1016/j.clinbiochem.2014.05.056
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Objective: Failure to adequately communicate a laboratory critical value (CV) is a potential cause of adverse events. The harmonization of CV reporting is increasingly recognized as a key issue in ensuring patient care and minimizing harm. With ongoing improvements in CV reporting, the patient's outcome should be audited to assess the effectiveness of CV notification. Design and methods: We report the data audited throughout a six month-period duri ng which an analysis was made of CVs, and we describe the approach of clinicians and general practitioners (GPs), and their decision making following CV reporting. Results: CV notification led to a change of treatment in 98.0% of patients admitted to surgical and in 90.6% of those admitted to medical wards. Clinicians made a further evaluation of new complications in patients in 70.0% and 60.4% of cases, in surgical and medical wards respectively. In more than 40.0% of cases, CVs were unexpected findings. In the primary care setting, critical hyperkalemia was managed by GPs in 55% of patients, thus sparing patient's hospitalization. For all outpatients with critical INR (international normalized ratio), the GPs changed or stopped warfarin dosage. Twenty-four percent of patients were checked for an additional INR, whereas a further medical examination by a consultant in the hospital setting was requested for 5% of patients. Conclusions: The laboratory plays a key role in ensuring patient safety, especially in CV reporting. An evaluation should be made of the patient's outcome and clinical decision making in order to assess the effectiveness of the CV process. (C) 2014 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:1163 / 1168
页数:6
相关论文
共 27 条
[1]  
[Anonymous], MLO MED LAB OBS
[2]  
[Anonymous], 2012, 15189 ISO
[3]  
[Anonymous], CLIN CHIM ACTA
[4]  
[Anonymous], CLIN CHIM ACTA
[5]  
[Anonymous], 2014, National patient safety goals
[6]   Errors in a stat laboratory: Types and frequencies 10 years later [J].
Carraro, Paolo ;
Plebani, Mario .
CLINICAL CHEMISTRY, 2007, 53 (07) :1338-1342
[7]   Critical result communication response to Piva and Plebani: Best practices for communicating critical values [J].
Derzon, James H. ;
Liebow, Edward B. .
CLINICAL BIOCHEMISTRY, 2013, 46 (1-2) :185-186
[8]   Laboratory defined critical value limits: How do hospital physicians perceive laboratory based critical values? [J].
Don-Wauchope, Andrew C. ;
Chetty, Vasudhevan T. .
CLINICAL BIOCHEMISTRY, 2009, 42 (09) :766-770
[9]   When diagnostic testing leads to harm: a new outcomes-based approach for laboratory medicine [J].
Epner, Paul L. ;
Gans, Janet E. ;
Graber, Mark L. .
BMJ QUALITY & SAFETY, 2013, 22 :ii6-ii10
[10]   Critical values for the maternal-fetal unit, fetus, infant, child and adolescent: Bilirubin reporting practice in North American Children's Hospitals as a paradigm for critical value reporting assessment [J].
Geaghan, Sharon M. .
CLINICAL BIOCHEMISTRY, 2011, 44 (07) :483-484